Mirati Therapeutics Inc logo

Mirati Therapeutics Inc

$ 67.99 -0.37 (-0.54%) 10:08 PM EST
P/E:
At Loss
P/B:
3.39
Market Cap:
$ 3.78B
Enterprise V:
$ 2.67B
Volume:
962.09K
Avg Vol (2M):
889.12K
Also Trade In:
Volume:
962.09K
Market Cap $:
3.78B
PE Ratio:
At Loss
Avg Vol (2-Month):
889.12K
Enterprise Value $:
2.67B
PB Ratio:
3.39
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 23.57
Equity-to-Asset 0.87
Debt-to-Equity 0.05
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.75
Distress
Grey
Safe
Beneish M-Score 0.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.21
9-Day RSI 30.9
14-Day RSI 36.22
6-1 Month Momentum % -8.66
12-1 Month Momentum % -52.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.1
Quick Ratio 10.1
Cash Ratio 9.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.4

Financials (Next Earnings Date:2022-11-08 Est.)

MRTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MRTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 78.163
EPS (TTM) ($) -11.85
Beta 0.34
Volatility % 102.78
14-Day RSI 36.22
14-Day ATR ($) 4.077717
20-Day SMA ($) 75.368
12-1 Month Momentum % -52.24
52-Week Range ($) 32.96 - 195.99
Shares Outstanding (Mil) 55.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mirati Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Mirati Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.